More recently, the discovery of the interaction of the coactivator bromodomain-containing protein (BRD4) with YAP-TAZ-TEAD1 to enhance the transcription of cancer related genes opened the way for new therapeutic strategies targeting BRD proteins to inhibit YAP activity in tumors [13]. Here, WWTR1 is linked to cancer.